Séverine Vermeire, MD, Phd

Gastroenterology

Séverine Vermeire obtained her MD from KU Leuven in 1995 and a PhD at the same University in 2001. She further trained at the Universidad Nacional de Asuncion, Paraguay (1993), at the Wellcome Trust Centre for Human Genetics in Oxford, UK (1997-1998) and at the Montreal General Hospital McGill University Canada in 2000–2001. She is staff member at the Gastroenterology & Hepatology Department of the University Hospital Leuven and Full Professor of Medicine at the KU Leuven. Since 2021, she is Research Director of Biomedical Sciences at KU Leuven.

Prof. Vermeire is actively involved as principle investigator in RCTs with new therapeutic compounds and has been lead investigator on several of these programs. Her scientific work resulted in more than 600 peer-reviewed articles and focusses on the role of the microbiome and genetic susceptibility in IBD and on identifying prognostic and predictive signatures of treatment response. She participated in the International iCHOM consortium on development of Patient-Centered Outcomes for Inflammatory Bowel Disease.

She was awarded an Advanced H2020-European Research Council (ERC) Grant (2016-2022) and was President of the European Crohn’s and Colitis Organisation (ECCO) from 2014-2016 and of the  Belgian IBD Research & Development (BIRD) Group from 2011-2013.